Start Free Trial
Pricing
Log In
Log In
Upgrade browser for full Crunchbase experience. You're accessing Crunchbase in a browser that is no longer supported.
Learn More
Medac Pharma Logo
Medac Pharma Growth Score
22
CB Rank
583083
Heat Score
67
Medac Pharma specializes in the development and treatment of cancer, autoimmune diseases, and urological diseases.
Acquired by
Medexus Pharma Logo
Medexus Pharma
Founded
obfuscation
Private Stirling, Stirling, United Kingdom11-50 medacpharma.co.uk/
Medical
Pharmaceutical
Therapeutics
Overview

Medac Pharma
Growth Score
22
Heat Score
67

Growth Score22
-6 pts
in past quarter
Heat Score 67
-3 pts
in past quarter

Company Performance Metrics

Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
Learn More >
See more interactive data and historical milestones on desktop for the best experience

About Medac Pharma

CB Rank
583083
Medac Pharma specializes in the development and treatment of cancer, autoimmune diseases, and urological diseases.
Acquired by
Medexus Pharma Logo
Medexus Pharma
Founded
obfuscation
Private Stirling, Stirling, United Kingdom11-50 medacpharma.co.uk/
Medical
Pharmaceutical
Therapeutics

Details

Sub-Organization of 
Medexus Pharma Logo
Medexus Pharma
Legal Name Medac Pharma, LLC.
Operating Status Active
Company Type For Profit
Phone Number +44-178-645-8086
Contact Email info@medacpharma.co.uk
Predictions & Insights

Growth Prediction

See this Growth Prediction

Products & Services

BCG-medac
A powder and solvent formulation of Bacillus Calmette Guérin for intravesical suspension used in urology.
Carmustine medac
A powder and solvent concentrate for infusion used in hematology for cancer treatment.

Unlock More with Crunchbase Pro
  • Full access to financial & funding data on unlimited profiles
  • Export up to 2k results/month for analysis
  • Track market signals on competitors, products, and R&D
  • Preview private company insights and predictions
Financials

M&A Details

Medac Pharma merged with Medexus Pharma for
obfuscation
on
obfuscation
. This deal was done in Cash & Stock.
Transaction Name 
Medac Pharma acquired by Medexus Pharma Logo
Medac Pharma acquired by Medexus Pharma
Acquired by 
Medexus Pharma Logo
Medexus Pharma
Announced Date 
obfuscation
Price 
obfuscation
Market Intelligence
People
View Profiles & Contacts
Headcount 11-50 Contacts 5
News

News and Press

News•Mar 25, 2025
obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated
Access a complete feed of recent news and press, from product launches to leadership changes.
Technology
View Tech Report

Monthly Web Visits

137
-39.11%
 in past month

IT Spend

$144.6KThis year, Medac Pharma is projected to spend $144.6K on IT, according to Aberdeen.

Active Website Tech Count

27Medac Pharma is actively using 27 technologies for its website, according to BuiltWith. These include IPhone / Mobile Compatible, Viewport Meta, and  SSL by Default.
Sub-Organizations
Frequently Asked Questions

Where is Medac Pharma's headquarters? Medac Pharma is located in Stirling, Stirling, United Kingdom.Who are Medac Pharma's competitors? Alternatives and possible competitors to Medac Pharma may include Pfizer, Novartis, and  Teva Pharmaceuticals.
Who We Are
What We Do
Helpful Links
AI Content may contain mistakes and is not legal, financial or investment advice. Learn more.
Terms of Service | Privacy Policy | Sitemap | © 2026 Crunchbase Inc. All Rights Reserved.
(55a1db1 1)
|